Streetbeat News

ALTS

ALT5 Sigma Corporation

Industry

Software - Application

ALT5 Sigma Corporation operates a next generation blockchain platform. It engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. The company's products include ALT 5 Prime, an electronic over-the-counter trading platform to buy and sell digital assets; and ALT 5 Pay that enables payment processors to accept digital assets as payments, as well as make payment in digital assets. It is also involved in the developing of solutions for opioid crisis. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

In Thursday's pre-market session, several healthcare stocks experienced significant price movements. Theriva Biologics, Conduit Pharmaceuticals, and ENDRA Life Sciences were among the top gainers, while Windtree Therapeutics, Soligenix, and Kazia Therapeutics saw notable declines.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 12:06 pm

ALT5 plans to separate into two independent publicly traded companies, focusing on fintech and biotech. The fintech segment will remain as ALT5, while the biotech segment will become Alyea Therapeutics Corporation, focusing on non-addictive pain management therapies.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:35 pm

ALT5 Sigma has appointed Peter Tassiopoulos as the new CEO, while Tony Issac transitions to the role of President and continues as Chairman of the Board. This leadership change may impact the company's strategic direction.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 12:48 pm

ALT5 Sigma Corporation (NASDAQ:ALTS) reported Q2 fintech revenues of $2.17M and an EPS of $0.07. The company showed significant growth in net income and gross profit, indicating strong financial performance.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 7:01 am

Nikola Corporation's shares fell by 10.4% after announcing a securities purchase agreement and a mixed shelf offering. Other stocks like Alzamend Neuro and Virax Biolabs saw significant gains, while Liquidia Corporation and Theriva Biologics experienced notable declines.

Portfolio Pulse from Avi Kapoor

August 19, 2024 | 5:37 pm

Xperi Inc. (NYSE:XPER) shares rose 11.6% in pre-market trading after announcing an $80 million asset sale agreement with Amazon.com services. Other notable pre-market movers include Applied DNA Sciences, Inc. (NASDAQ:APDN) up 130%, GeoVax Labs, Inc. (NASDAQ:GOVX) up 56%, and fuboTV Inc. (NYSE:FUBO) up 8.5% following a legal win against major media companies.

Portfolio Pulse from Avi Kapoor

August 19, 2024 | 9:18 am

ALT5 Sigma shares are trading higher following the company's report of a year-over-year increase in July revenue results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 4:16 pm

ALT5 Sigma Corporation (NASDAQ:ALTS) reported a significant increase in transaction volume for July 2024, reaching $179.35 million, up 114% from $83.81 million in July 2023. The year-to-date transaction volume is $1.05 billion, a 101% increase year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:59 pm

ALT5 Sigma Corporation reported a transaction volume of $879 million for Q1 and Q2 2024, marking a 99% year-over-year increase. The transaction volume for June 2024 alone reached $124 million, up 68% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:41 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.